3 Medicare Changes All Retirees Need to Know About to Begin 2026

Medicare changes taking effect in 2026 raise standard Part B premiums to $202.90/month (up $17.90 from $185), which may offset recipients' 2.8% COLA benefit. CMS launched a six-year prior-authorization pilot called WISeR in Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington targeting procedures and devices deemed wasteful (e.g., certain knee surgeries, skin grafts, stimulators) to curb taxpayer spending. In addition, Medicare is tightening telehealth coverage effective Jan. 31, generally requiring beneficiaries to be in a rural physical medical facility for coverage, with limited clinical exceptions (behavioral health, kidney care, stroke evaluations).

Analysis

Market structure: Medicare changes (Part B +$17.90 to $202.90/mo; WISeR pilot in 6 states; telehealth rollback effective Jan 31) shift demand away from elective surgical volume and pure-telehealth visits and toward managed-care cost management, utilization-review tech, and facility-based care. Winners: Medicare Advantage insurers (UNH, HUM, CVS) and prior‑auth automation vendors; losers: elective orthopedics/device makers (SYK, ZBH, JNJ) and virtual-first telehealth names (TDOC). Expect 2–7% annualized volume pressure in targeted elective categories inside pilot geographies in first 12–24 months.

Risk assessment: Tail risks include federal expansion of WISeR nationwide (high impact) or successful legal/industry pushback (reversal). Near-term (0–3 months) volatility will be driven by CMS reports and state adoption cadence; mid-term (3–12 months) by utilization datapoints and earnings misses at device providers; long-term (12–36 months) by whether pilots become permanent. Hidden dependencies: CMS savings targets could spur private payor mirroring, amplifying impact beyond Medicare; regulatory clarity or insurer-provider litigation are key catalysts.

Trade implications: Tactical ideas — overweight MA insurers (UNH/HUM) for 6–12 months and hedge with short exposure to SYK/ZBH; buy 60–120 day put spreads on TDOC to express telehealth downside around next quarterly results; consider 1–2% allocation to niche prior‑auth automation software or revenue-cycle names (public comparables or small caps) for 12–24 months. Use pair trades (long UNH, short SYK) to isolate utilization risk; size positions so single-name risk ≤3% of portfolio.

Contrarian angles: Consensus underestimates beneficiaries for companies enabling prior‑auth (automation SaaS, analytics) and ambulatory surgery centers that can concentrate approved cases — these could see 5–10% revenue uplift if hospitals lose elective share. Reaction may be overdone for diversified device giants (JNJ) where elective exposure is a fraction of total revenue; avoid broad sector sells, prefer targeted short on product lines most exposed. Monitor CMS WISeR quarterly metrics and state-level adoption thresholds (if >4 states adopt within 12 months, escalate short sizing).

Key Decisions for Investors

• Establish a 2–3% long position split equally between UNH and HUM (1–1.5% each) over the next 2–6 weeks; target horizon 6–12 months, take-profit +15–25%, stop-loss -8% to capture MA margin tailwind from utilization controls.
• Enter a 1.5–2% short exposure to SYK and ZBH (0.75–1% each) via stock or synthetic short to reflect expected 3–7% elective volume hit in pilot states over 12 months; cover if CMS signals rollback or pilot remains localized beyond 24 months.
• Buy 60–120 day put spreads on TDOC sized to 0.5–1% portfolio risk (e.g., 1:1 debit put spread ~20–25% width) ahead of next quarterly results to capture telehealth demand normalization risk; unwind on >20% move against position or at expiry.
• Allocate 1–2% to public or small‑cap vendors that automate prior authorization/revenue-cycle management (target names with >40% SaaS revenue and positive free cash flow) for 12–24 months; exit if CMS WISeR metrics show <5% utilization reduction after first year.
• Implement a pair trade: long 1.5% UNH / short 1.5% SYK to isolate utilization risk; increase short leg to 2.5% if CMS expands WISeR to additional states beyond the initial six within 12 months.